Lincoln Pharmaceuticals Ltd. - Research Center
531633 LINCOLN Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 510.31 | 472.08 | 413.06 | 376.09 | 353.04 |
| Operating profit | 89.17 | 95.47 | 81.35 | 59.37 | 60.33 |
| Interest | 2.03 | 1.45 | 1.44 | 1.98 | 3.84 |
| Gross profit | 109.62 | 104.02 | 86.68 | 69.52 | 63.06 |
| EPS (Rs) | 36.40 | 34.63 | 30.20 | 24.78 | 23.32 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 22.48 | 10.00 | 6.77 | 12.13 | 6.58 |
| Stock adjustment | -4.24 | -13.57 | 1.35 | -5.86 | 7.33 |
| Raw material | 177.00 | 158.48 | 95.50 | 101.97 | 80.84 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 93.16 | 70.47 | 56.47 | 54.90 | 48.40 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 155.23 | 161.23 | 178.39 | 165.71 | 156.14 |
| Provisions made | - | - | - | - | - |
| Depreciation | 9.17 | 8.09 | 5.67 | 5.47 | 4.92 |
| Taxation | 27.56 | 26.57 | 20.61 | 14.48 | 11.51 |
| Net profit / loss | 72.90 | 69.36 | 60.41 | 49.56 | 46.64 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 20.03 | 20.03 | 20.00 | 20.00 | 20.00 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 17.47 | 20.22 | 19.69 | 15.79 | 17.09 |
| GPM (%) | 20.57 | 21.58 | 20.65 | 17.91 | 17.54 |
| NPM (%) | 13.68 | 14.39 | 14.39 | 12.77 | 12.97 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis